Dr. Haddad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 2004 - 2007
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2001 - 2004
- Creighton University School of MedicineClass of 2001
- Marquette UniversityB.S., Biology, Magna Cum Laude, 1991 - 1995
Certifications & Licensure
- MN State Medical License 2002 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- HIMSS Future50 Clinical Leader Health Information and Management Systems Society, 2021
- Best Teacher- New Faculty, by the Mayo Clinic Internal Medicine Residency Program 2013
- Department of Medicine Educational Excellence Award 2008
- Join now to see all
Clinical Trials
- Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
- Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery Start of enrollment: 2014 Dec 05
- Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer Start of enrollment: 2017 Jul 06
- Join now to see all
Publications & Presentations
PubMed
- Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.Elias, A., Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, A Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M Wallace, Henry Kapla...> ;Clinical Cancer Research. 2024 Feb 16
- TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.Filipa Lynce, Laura E Stevens, Zheqi Li, Jane E Brock, Anushree Gulvady, Ying Huang, Faina Nakhlis, Ashka Patel, Jeremy M Force, Tufia C Haddad, Naoto Ueno, Vered Stea...> ;Breast Cancer Research. 2024 Jan 31
- Feasibility and Usability of a Mobile App-Based Interactive Care Plan for Migraine in a Community Neurology Practice: Development and Pilot Implementation Study.Nathan P Young, Jennifer L Ridgeway, Tufia C Haddad, Sarah B Harper, Lindsey M Philpot, Laura A Christopherson, Samantha M McColley, Sarah A Phillips, Julie K Brown, K...> ;JMIR Formative Research. 2023 Oct 5
- Join now to see all
Journal Articles
- Smoking and quality of life among survivors of breast, colorectal and endometrial cancers in a prospective cohort studyJang S, Prizment A, Haddad T, Robien K, Lazovich D, J Cancer Surviv, 1/1/2011
- Nonpharmacologic Complementary Therapies for Symptom Management in Breast Cancer SurvivorsBlaes A, Kreitzer MJ, Torkelson C, Haddad T, Semin Oncol, 1/1/2011
- Conflict of interest in economic analysis of aromatase inhibitors in breast cancer: a systematic reviewJang S, Chae YK, Haddad T, and Majhail N, Breast Cancer Res Treat, 1/1/2010
- Join now to see all
Press Mentions
- Leading Scientists Share Advances in Omics-Based Clinical Trials at 12th Annual Individualizing Medicine ConferenceMay 3rd, 2023
- Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA OncologyMarch 14th, 2023
- New York Approves AI-Driven Breast Cancer DiagnosticFebruary 7th, 2023
- Join now to see all
Professional Memberships
- Member
- American Association of Cancer ResearchMember
- Healthcare Information and Management Systems SocietyMember
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: